Stocks / JNJ vs LLY

JNJ vs LLY: Which Stock Wins?

Johnson & Johnson vs Eli Lilly and Co — side by side on the metrics that matter, plus a free AI rating and price targets on each.

On current data, JNJ screens stronger across valuation, momentum & analyst consensus (2 of 3 signals).

JNJ

Pharmaceuticals

LLY

Pharmaceuticals

$237.00

$1144.68

PRICE

◀ +2.08%

-0.39%

TODAY

$570.5B

$1.08T

MARKET CAP

◀ 21.3

53.1

P/E RATIO

0.24

0.51

BETA

86%

93%

52W POSITION

Strong Buy

Strong Buy ▶

ANALYST VIEW

Run AI analysis on JNJ →Run AI analysis on LLY →

JNJ vs LLY FAQ

Is JNJ or LLY the better stock?

On current data, Johnson & Johnson (JNJ) screens stronger across valuation, momentum and analyst consensus. "Better" depends on your thesis and time horizon — run each through the free YN Finance AI Analyzer for a full rating and price targets.

JNJ vs LLY: which is cheaper?

JNJ trades at a P/E of 21.3 versus 53.1 for LLY. Lower isn't automatically better — context matters.

Popular comparisons

AAPL vs MSFT NVDA vs AMD TSLA vs RIVN GOOGL vs META AMZN vs WMT V vs MA JPM vs BAC KO vs PEP NVDA vs TSM MSFT vs GOOGL AMD vs INTC SHOP vs AMZN

Data via Finnhub, refreshed hourly. Not financial advice — educational purposes only. "Screens stronger" reflects current quantitative metrics, not a recommendation.